Docusign (NASDAQ:DOCU) had its price objective boosted by Deutsche Bank from $70.00 to $80.00 in a research report sent to investors on Friday, BenzingaRatingsTable reports. They currently have a buy rating on the stock.
Several other research analysts have also recently weighed in on DOCU. Royal Bank of Canada upped their price objective on shares of Docusign from $80.00 to $93.00 and gave the stock an outperform rating in a research report on Monday, December 2nd. Bank of America lifted their target price on shares of Docusign from $57.00 to $62.00 and gave the company a neutral rating in a research report on Friday, September 6th. JPMorgan Chase & Co. boosted their price target on shares of Docusign from $88.00 to $90.00 and gave the stock an overweight rating in a research note on Friday, September 6th. Danske started coverage on shares of Docusign in a research note on Friday, August 16th. They issued a buy rating and a $52.00 price target for the company. Finally, KeyCorp set a $65.00 price target on shares of Docusign and gave the stock a buy rating in a report on Friday, September 6th. Five equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. The company currently has an average rating of Buy and a consensus price target of $74.75.
Shares of NASDAQ DOCU opened at $75.57 on Friday. The firm has a market capitalization of $13.30 billion, a P/E ratio of -26.06 and a beta of 1.46. The company has a quick ratio of 1.64, a current ratio of 1.64 and a debt-to-equity ratio of 1.06. The stock’s 50-day simple moving average is $67.85 and its two-hundred day simple moving average is $57.15. Docusign has a twelve month low of $36.25 and a twelve month high of $75.85.
Docusign (NASDAQ:DOCU) last released its quarterly earnings results on Thursday, December 5th. The company reported $0.11 earnings per share for the quarter, beating the consensus estimate of $0.03 by $0.08. The firm had revenue of $249.50 million for the quarter, compared to analysts’ expectations of $240.40 million. Docusign had a negative return on equity of 26.51% and a negative net margin of 25.28%. The business’s revenue was up 39.9% on a year-over-year basis. As a group, research analysts anticipate that Docusign will post -1.04 EPS for the current fiscal year.
In related news, CTO Kirsten O. Wolberg sold 7,877 shares of Docusign stock in a transaction on Wednesday, September 25th. The shares were sold at an average price of $61.29, for a total value of $482,781.33. Also, COO Scott V. Olrich sold 2,000 shares of Docusign stock in a transaction on Wednesday, November 13th. The stock was sold at an average price of $66.69, for a total transaction of $133,380.00. Following the completion of the transaction, the chief operating officer now owns 497,770 shares in the company, valued at approximately $33,196,281.30. The disclosure for this sale can be found here. Insiders sold a total of 40,698 shares of company stock valued at $2,613,209 in the last 90 days. 13.60% of the stock is currently owned by corporate insiders.
A number of hedge funds and other institutional investors have recently bought and sold shares of DOCU. North Star Investment Management Corp. bought a new position in shares of Docusign during the third quarter valued at about $25,000. Hartford Financial Management Inc. bought a new stake in shares of Docusign in the 3rd quarter valued at about $31,000. Whittier Trust Co. lifted its stake in shares of Docusign by 229.4% in the 3rd quarter. Whittier Trust Co. now owns 560 shares of the company’s stock valued at $35,000 after acquiring an additional 390 shares during the last quarter. Wealthcare Advisory Partners LLC bought a new stake in shares of Docusign in the 2nd quarter valued at about $36,000. Finally, Migdal Insurance & Financial Holdings Ltd. boosted its holdings in Docusign by 261.0% during the 2nd quarter. Migdal Insurance & Financial Holdings Ltd. now owns 769 shares of the company’s stock valued at $38,000 after acquiring an additional 556 shares during the period. Institutional investors and hedge funds own 81.66% of the company’s stock.
Docusign Company Profile
DocuSign, Inc provides cloud based software in the United States. The company offers e-signature solution that enables businesses to digitally prepare, execute, and act on agreements. The company sells its products through direct, partner-assisted, and Web-based sales. It serves enterprise businesses, commercial businesses, and small businesses, such as professionals, sole proprietorships and individuals.
Read More: Technical Analysis
Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.